News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
374,158 Results
Type
Article (15542)
Company Profile (114)
Press Release (358502)
Multimedia
Podcasts (40)
Webinars (7)
Section
Business (114393)
Career Advice (522)
Deals (18910)
Drug Delivery (32)
Drug Development (33292)
Employer Resources (53)
FDA (9007)
Job Trends (7984)
News (177036)
Policy (12793)
Tag
Academia (1362)
Accelerated approval (3)
Allergies (42)
Alliances (35160)
ALS (28)
Alzheimer's disease (546)
Antibody-drug conjugate (ADC) (92)
Approvals (9048)
Artificial intelligence (260)
Autoimmune disease (5)
Automation (14)
Bankruptcy (131)
Best Places to Work (6788)
BIOSECURE Act (7)
Biosimilars (14)
Biotechnology (86)
Bladder cancer (32)
Brain cancer (14)
Breast cancer (186)
Cancer (1239)
Cardiovascular disease (74)
Career advice (458)
Career pathing (9)
CAR-T (117)
Cell therapy (293)
Cervical cancer (12)
Clinical research (26316)
Collaboration (648)
Compensation (124)
Complete response letters (3)
COVID-19 (1186)
CRISPR (41)
C-suite (156)
Cystic fibrosis (58)
Data (1146)
Decentralized trials (1)
Denatured (18)
Depression (18)
Diabetes (113)
Diagnostics (4958)
Digital health (17)
Diversity (4)
Diversity, equity & inclusion (11)
Drug discovery (79)
Drug pricing (17)
Drug shortages (6)
Duchenne muscular dystrophy (28)
Earnings (39951)
Editorial (2)
Employer branding (8)
Employer resources (46)
Events (53041)
Executive appointments (434)
FDA (9767)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (508)
Gene editing (95)
Generative AI (25)
Gene therapy (192)
GLP-1 (259)
Government (1314)
Grass and pollen (2)
Guidances (92)
Healthcare (10129)
Huntington's disease (6)
IgA nephropathy (12)
Immunology and inflammation (37)
Indications (14)
Infectious disease (1264)
Inflammatory bowel disease (67)
Inflation Reduction Act (3)
Influenza (33)
Intellectual property (65)
Interviews (69)
IPO (8187)
IRA (9)
Job creations (1489)
Job search strategy (401)
Kidney cancer (4)
Labor market (11)
Layoffs (136)
Leadership (3)
Legal (2592)
Liver cancer (44)
Lung cancer (152)
Lymphoma (71)
Machine learning (7)
Management (19)
Manufacturing (205)
MASH (19)
Medical device (11555)
Medtech (11560)
Mergers & acquisitions (11107)
Metabolic disorders (243)
Multiple sclerosis (33)
NASH (3)
Neurodegenerative disease (36)
Neuropsychiatric disorders (4)
Neuroscience (760)
NextGen: Class of 2025 (3617)
Non-profit (1612)
Now hiring (9)
Obesity (107)
Opinion (82)
Ovarian cancer (46)
Pain (53)
Pancreatic cancer (45)
Parkinson's disease (72)
Partnered (13)
Patents (158)
Patient recruitment (64)
Peanut (26)
People (33181)
Pharmaceutical (16)
Phase I (9617)
Phase II (11895)
Phase III (7828)
Pipeline (713)
Policy (35)
Postmarket research (551)
Preclinical (4303)
Press Release (66)
Prostate cancer (50)
Psychedelics (5)
Radiopharmaceuticals (171)
Rare diseases (152)
Real estate (3436)
Recruiting (21)
Regulatory (9752)
Reports (19)
Research institute (1314)
Resumes & cover letters (85)
Rett syndrome (5)
RNA editing (2)
RSV (23)
Schizophrenia (13)
Series A (92)
Series B (57)
Service/supplier (7)
Sickle cell disease (19)
Special edition (2)
Spinal muscular atrophy (59)
Sponsored (13)
Startups (2535)
State (2)
Stomach cancer (3)
Supply chain (29)
Tariffs (7)
The Weekly (21)
Vaccines (340)
Venture capitalists (19)
Weight loss (47)
Women's health (18)
Worklife (2)
Date
Today (72)
Last 7 days (497)
Last 30 days (1724)
Last 365 days (17451)
2025 (6412)
2024 (19242)
2023 (22606)
2022 (31472)
2021 (33296)
2020 (31287)
2019 (26463)
2018 (19976)
2017 (19396)
2016 (18215)
2015 (21012)
2014 (15452)
2013 (12985)
2012 (13974)
2011 (14314)
2010 (13045)
Location
Africa (333)
Alabama (42)
Alaska (6)
Arizona (127)
Arkansas (10)
Asia (24636)
Australia (4289)
California (3257)
Canada (1130)
China (284)
Colorado (177)
Connecticut (138)
Delaware (55)
Europe (50512)
Florida (526)
Georgia (143)
Idaho (33)
Illinois (302)
India (13)
Indiana (176)
Iowa (5)
Japan (126)
Kansas (85)
Kentucky (7)
Louisiana (7)
Maine (20)
Maryland (489)
Massachusetts (2228)
Michigan (191)
Minnesota (266)
Mississippi (2)
Missouri (63)
Montana (25)
Nebraska (15)
Nevada (26)
New Hampshire (67)
New Jersey (1021)
New Mexico (16)
New York (924)
North Carolina (561)
North Dakota (8)
Northern California (1258)
Ohio (107)
Oklahoma (11)
Oregon (20)
Pennsylvania (655)
Puerto Rico (11)
Rhode Island (25)
South America (532)
South Carolina (24)
South Dakota (1)
Southern California (1327)
Tennessee (64)
Texas (523)
United States (12659)
Utah (114)
Virginia (60)
Washington D.C. (13)
Washington State (358)
West Virginia (3)
Wisconsin (42)
374,158 Results for "triple ring technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Breast cancer
Gilead’s Trodelvy, With Keytruda, Slows Disease Progression in Triple-Negative Breast Cancer
Combining Trodelvy with Keytruda and pushing it into the frontline setting could “potentially double” the ADC’s market in metastatic triple-negative breast cancer, according to analysts at Truist Securities.
April 22, 2025
·
2 min read
·
Tristan Manalac
Weight loss
Novo Challenges Lilly With up to $2B Bet for Triple-G Obesity Drug From Chinese Biotech
Novo will license UTB251, a triple hormone receptor agonist that in mid-2023 achieved 24% weight reduction at 48 weeks in a mid-stage study.
March 24, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Ring Therapeutics Presents New Data on its AnelloBricks® Manufacturing Platform at the 28th Annual American Society of Gene & Cell Therapy Conference
May 13, 2025
·
5 min read
Press Releases
Mersana Therapeutics Announces Strategic Restructuring and Reprioritization Plan Focused on Advancing Emi-Le in Triple-Negative Breast Cancer
May 7, 2025
·
6 min read
Legal
Novo Enters the Ring in Legal Fight Against GLP-1 Compounders as Lilly Notches Victory
Novo Nordisk is intervening in the lawsuit filed by a drug compounders trade group against the FDA over the agency’s decision to declare the Wegovy shortage over. Eli Lilly did the same in a parallel case over Zepbound’s removal from the FDA shortage list and this week a judge denied the compounders’ injunction.
March 6, 2025
·
3 min read
·
Kate Goodwin
Press Releases
Trodelvy® Plus Keytruda® Demonstrates a Statistically Significant and Clinically Meaningful Improvement in Progression Free Survival in Patients With Previously Untreated PD-L1+ Metastatic Triple-Negative Breast Cancer
April 21, 2025
·
17 min read
Pharm Country
Amneal to Ring the Nasdaq Closing Bell on April 2, 2024
Amneal Pharmaceuticals, Inc., a global pharmaceutical company, announced that Chirag and Chintu Patel, Co-founders and Co-Chief Executive Officers, will ring the Nasdaq closing bell on Tuesday, April 2, 2024.
March 28, 2024
·
1 min read
Drug Development
AstraZeneca’s Truqap Flops in Phase III Triple-Negative Breast Cancer Trial
Bucking its recent winning streak in oncology, AstraZeneca reported Tuesday that its AKT inhibitor Truqap failed to significantly boost overall survival in patients with triple-negative breast cancer.
June 18, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Novotech Releases Report on Current State of Triple-Negative Breast Cancer Clinical Trials
January 16, 2025
·
3 min read
Press Releases
Akeso Enrolled First Patient in The Phase III Clinical Trial of Ivonescimab in Combination with Chemotherapy for First-Line Treatment of Triple-Negative Breast Cancer
February 21, 2025
·
4 min read
1 of 37,416
Next
